These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22955060)

  • 1. Induced genome maintenance pathways in pre-cancer tissues describe an anti-cancer barrier in tumor development.
    Simão ÉM; Sinigaglia M; Bugs CA; Castro MA; Librelotto GR; Alves R; Mombach JC
    Mol Biosyst; 2012 Nov; 8(11):3003-9. PubMed ID: 22955060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA double-strand breaks: signaling, repair and the cancer connection.
    Khanna KK; Jackson SP
    Nat Genet; 2001 Mar; 27(3):247-54. PubMed ID: 11242102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of p53-mediated apoptosis as a crucial anti-tumor response to genomic instability: lessons from mouse models.
    Attardi LD
    Mutat Res; 2005 Jan; 569(1-2):145-57. PubMed ID: 15603759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells.
    Wani MA; Zhu Q; El-Mahdy M; Venkatachalam S; Wani AA
    Cancer Res; 2000 Apr; 60(8):2273-80. PubMed ID: 10786695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Catulin knockdown induces senescence in cancer cells.
    Fan LC; Chiang WF; Liang CH; Tsai YT; Wong TY; Chen KC; Hong TM; Chen YL
    Oncogene; 2011 Jun; 30(23):2610-21. PubMed ID: 21278790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taiwanin A inhibits MCF-7 cancer cell activity through induction of oxidative stress, upregulation of DNA damage checkpoint kinases, and activation of p53 and FasL/Fas signaling pathways.
    Shyur LF; Lee SH; Chang ST; Lo CP; Kuo YH; Wang SY
    Phytomedicine; 2010 Dec; 18(1):16-24. PubMed ID: 20637573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cell cycle regulation after exposure to ionizing radiation].
    Teyssier F; Bay JO; Dionet C; Verrelle P
    Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells.
    Li Y; Shao J; Shen K; Xu Y; Liu J; Qian X
    J Cell Biochem; 2012 Oct; 113(10):3165-77. PubMed ID: 22593008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mycotoxin Zearalenone induces apoptosis in human hepatocytes (HepG2) via p53-dependent mitochondrial signaling pathway.
    Ayed-Boussema I; Bouaziz C; Rjiba K; Valenti K; Laporte F; Bacha H; Hassen W
    Toxicol In Vitro; 2008 Oct; 22(7):1671-80. PubMed ID: 18662769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells.
    Puca R; Nardinocchi L; Givol D; D'Orazi G
    Oncogene; 2010 Aug; 29(31):4378-87. PubMed ID: 20514025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells.
    Satyamoorthy K; Chehab NH; Waterman MJ; Lien MC; El-Deiry WS; Herlyn M; Halazonetis TD
    Cell Growth Differ; 2000 Sep; 11(9):467-74. PubMed ID: 11007451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
    Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
    Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision making by p53: life, death and cancer.
    Oren M
    Cell Death Differ; 2003 Apr; 10(4):431-42. PubMed ID: 12719720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [p53-independent signaling pathway in DNA damage-induced cell apoptosis].
    Zhang X; Jiang Y; Yang J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Mar; 42(2):217-23. PubMed ID: 23585010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
    Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
    Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis and stress response in ovarian carcinoma cell lines treated with ST1926, an atypical retinoid.
    Zuco V; Zanchi C; Cassinelli G; Lanzi C; Supino R; Pisano C; Zanier R; Giordano V; Garattini E; Zunino F
    Cell Death Differ; 2004 Mar; 11(3):280-9. PubMed ID: 14657960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53.
    Fang L; Igarashi M; Leung J; Sugrue MM; Lee SW; Aaronson SA
    Oncogene; 1999 May; 18(18):2789-97. PubMed ID: 10362249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prosurvival activity of p53 protects cells from UV-induced apoptosis by inhibiting c-Jun NH2-terminal kinase activity and mitochondrial death signaling.
    Lo PK; Huang SZ; Chen HC; Wang FF
    Cancer Res; 2004 Dec; 64(23):8736-45. PubMed ID: 15574785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells.
    Cui Q; Yu JH; Wu JN; Tashiro S; Onodera S; Minami M; Ikejima T
    Acta Pharmacol Sin; 2007 Jul; 28(7):1057-66. PubMed ID: 17588343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines.
    Cosse JP; Sermeus A; Vannuvel K; Ninane N; Raes M; Michiels C
    Mol Cancer; 2007 Sep; 6():61. PubMed ID: 17894897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.